07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

RutuxiRel Rituximab Injections

Name: RutuxiRel Rituximab Injections
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 2200 INR
Availability: InStock

Price 2200 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

RutuxiRel Rituximab Injections Specification

Indication
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia

Dosage Form
Injection

Salt Composition
Rituximab

Feature
Lyophilized Powder

Ingredients
Rituximab

Application
Cancer Treatment

Physical Color/Texture
Clear solution

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C

Shelf Life
24 Months

Single Use Vial
Yes

Monoclonal Antibody
Yes

Admin Route
IV Infusion

Prescription Required
Yes

Also gives
PCD Pharma Franchise

Diluent Included
No

Packaging Type
Box

Packaging Size
10 ml

Strength
100 mg

RutuxiRel Rituximab Injections Trade Information

Minimum Order Quantity
1 Vial

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About RutuxiRel Rituximab Injections

RutuxiRel Rituximab Injections-illustrious for their redoubtable efficacy-offer a cost-effective solution in cancer therapy. Specially formulated as a lyophilized powder, this monoclonal antibody is designed for IV infusion, presenting best-in-class results in the treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. Packaged as a single-use 100 mg vial in a 10 ml box, its clear, odorless solution ensures clarity and purity. Featured for reliable performance, RutuxiRel can be redeemed through prescription, adhering to export and PCD pharma franchise opportunities across India. Store at 2C to 8C for optimal shelf life.

Application and Administration Insights

RutuxiRel Rituximab Injections are administered intravenously, ensuring precise delivery into the patient's bloodstream. The site of application is exclusively via IV infusion, under the direct supervision of qualified healthcare professionals. Designed for use on the internal vascular surface, this single-use vial provides a clear and consistent solution, optimizing absorption and therapeutic action. As a prescription-required product, it must only be applied in certified medical environments to guarantee patient safety and efficacy.

Certifications, Packaging, and Market Offerings

RutuxiRel Rituximab Injections meet stringent certification standards, underscoring their market value and reliability in cancer treatment. Offered in secure, clearly labeled box packaging containing a 100 mg single-use vial (10 ml), each proposal amount ensures quality and traceability. Targeted at India's main domestic market, these injections are distributed via reputed exporter and supplier channels. Reliable storage instructions and shelf life details further elevate the cost-effective appeal and competitiveness of RutuxiRel in the healthcare sector.

FAQ's of RutuxiRel Rituximab Injections:

Q: How should RutuxiRel Rituximab Injection be administered?

A: RutuxiRel Rituximab Injection is administered through IV infusion under professional medical supervision. The process involves precise preparation and dosage adjustment, as determined by your healthcare provider.

Q: What are the main benefits of using RutuxiRel Rituximab Injections?

A: RutuxiRel Rituximab Injections are renowned for their cost-effective, efficient results in treating Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia, offering improved patient outcomes under expert care.

Q: Where can RutuxiRel Rituximab Injections be obtained?

A: This medication is available via prescription through registered medical providers, authorized suppliers, or reliable pharmaceutical traders across India, including PCD Pharma Franchise channels.

Q: When is RutuxiRel Rituximab Injection typically indicated for use?

A: These injections are indicated for patients diagnosed with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia, as prescribed by a qualified oncologist.

Q: What packaging details does RutuxiRel offer?

A: RutuxiRel comes securely packaged as a single-use vial (100 mg in 10 ml), within a labeled box to ensure quality, safety, and transparency from supplier to end user.